We’re proud to share that NunaBio has won Innovation of the Year at the Pharma Industry Awards UK, held in London—one of the most competitive categories of the evening, with seven outstanding finalists.
This award recognises the development of our micro foundry platform (NB-3), a breakthrough in scalable DNA manufacturing. NB-3 enables the rapid, high-fidelity production of synthetic DNA at scale, unlocking new possibilities for research, therapeutics, and diagnostics. It’s a platform built not just on scientific ingenuity, but on collaboration.
A key part of this success was our partnership with BNC Engineering, who designed and built the hardware that powers NB-3. Their engineering excellence helped transform our vision into a robust, scalable reality.
Joe Hedley, CEO of NunaBio, shared his thoughts on the win:
“This award is a huge moment for NunaBio. NB-3 represents years of hard work, innovation, and belief in the power of synthetic biology to change the world. I’m incredibly proud of our team and grateful to BNC Engineering for their collaboration. Together, we’re building the future of DNA manufacturing.”
Winning Innovation of the Year is more than a trophy—it’s a validation of our mission to deliver DNA without boundaries. Our synthetic DNA is uniquely complex, customizable, and not available anywhere else. This recognition fuels our momentum as we continue to push the limits of what is possible in biotech.
Thank you to the Pharma Industry Awards UK for this honour, and to everyone who supports NunaBio’s journey. The future is bright—and we’re just getting started.
